Daily Judi: Friday, December 30, 2022
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Maryland-based Novavax, which created a current COVID-19 vaccine, is advancing phase 2 clinical trials of a combined vaccine targeting COVID-19 and influenza. (WTOP)
Science magazine examines Eisai's lecanemab clinical trial results.
After the news of soccer star Pelé passing away from colon cancer at age 82, Sarah Braner looks at U.S. clinical trials working toward new treatments to combat the disease. (Insider)
Our Culture
“We work proactively with each client, analyzing our reports to make them work faster, to help make our client’s life better.”
–Tim, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.
